Humanized mice in translational biomedical research
LD Shultz, F Ishikawa, DL Greiner - Nature Reviews Immunology, 2007 - nature.com
The culmination of decades of research on humanized mice is leading to advances in our
understanding of human haematopoiesis, innate and adaptive immunity, autoimmunity, …
understanding of human haematopoiesis, innate and adaptive immunity, autoimmunity, …
Humanized mice for immune system investigation: progress, promise and challenges
LD Shultz, MA Brehm, JV Garcia-Martinez… - Nature Reviews …, 2012 - nature.com
Significant advances in our understanding of the in vivo functions of human cells and tissues
and the human immune system have resulted from the development of 'humanized' mouse …
and the human immune system have resulted from the development of 'humanized' mouse …
Humanized mouse models of clinical disease
…, DL Greiner, MA Brehm, LD Shultz - Annual Review of …, 2017 - annualreviews.org
Immunodeficient mice engrafted with functional human cells and tissues, that is, humanized
mice, have become increasingly important as small, preclinical animal models for the study …
mice, have become increasingly important as small, preclinical animal models for the study …
The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function
JM McCune, R Namikawa, H Kaneshima, LD Shultz… - Science, 1988 - science.org
The study of human hematopoietic cells and the human immune system is hampered by the
lack of a suitable experimental model. Experimental data are presented showing that human …
lack of a suitable experimental model. Experimental data are presented showing that human …
The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene
…, S Nishikawa, H Okamura, T Sudo, LD Shultz… - Nature, 1990 - nature.com
MICE homozygous for the recessive mutation osteopetrosis (op) on chromosome 3 have a
restricted capacity for bone remodelling, and are severely deficient in mature macrophages …
restricted capacity for bone remodelling, and are severely deficient in mature macrophages …
Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγnull mice engrafted with mobilized human hemopoietic stem cells
LD Shultz, BL Lyons, LM Burzenski, B Gott… - The Journal of …, 2005 - journals.aai.org
Ethical considerations constrain the in vivo study of human hemopoietic stem cells (HSC). To
overcome this limitation, small animal models of human HSC engraftment have been used. …
overcome this limitation, small animal models of human HSC engraftment have been used. …
Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.
LD Shultz, PA Schweitzer, SW Christianson… - … (Baltimore, Md.: 1950 …, 1995 - journals.aai.org
… The development of the C57BW6Sz-scid genetic stock and its phenotype will be reported
elsewhere (LD Shultz, manuscript in preparation). Figure 5B shows the heightened …
elsewhere (LD Shultz, manuscript in preparation). Figure 5B shows the heightened …
Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region
…, O Ohara, K Akashi, M Harada, LD Shultz - Nature …, 2007 - nature.com
Acute myelogenous leukemia (AML) is the most common adult leukemia, characterized by
the clonal expansion of immature myeloblasts initiating from rare leukemic stem (LS) cells 1 , …
the clonal expansion of immature myeloblasts initiating from rare leukemic stem (LS) cells 1 , …
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
…, G Yoshimoto, T Watanabe, K Akashi, LD Shultz… - Blood, 2005 - ashpublications.org
Here we report that a new nonobese diabetic/severe combined immunodeficient (NOD/SCID)
mouse line harboring a complete null mutation of the common cytokine receptor γ chain (…
mouse line harboring a complete null mutation of the common cytokine receptor γ chain (…
Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene
Mice homozygous for the recessive allellc mutation motheaten (me) or viable motheaten (me’)
on chromosome 6 develop severe defects in hematopoiesis. In this paper we present the …
on chromosome 6 develop severe defects in hematopoiesis. In this paper we present the …